Invest
Potential Cures For Coronavirus Amidst Worsening Macroeconomic Conditions
By Investment Income for Life  •  April 20, 2020
There is a silver lining in the midst of all the fatalities and economic lock-down all over the world from the dreaded coronavirus outbreak in the form of many new drugs coming onboard for treatment. In Australia, scientists are working on testing an existing head lice anti-parasitic drug known as Ivermectin against the coronavirus which has been yielding great results in medical trials. In USA, a couple of anti-viral drugs are also being evaluated.
The most promising candidate that emerges recently from USA is Remdesivir developed by Gilead Sciences, Remdesivir was an Ebola drug that is being put on clinical trial. According to a report by The New England Journal of Medicine, Remdesivir, when administered to a coronavirus patient in the US, it appeared to have improved the clinical condition. Remdesivir is a nucleoside analogue that works by inhibiting viral reproduction. Dow Jones and S&P 500 stock indexes rallied 2% with...
Read the full article
By Investment Income for Life
I am an Accountant by training and is currently working in a global MNC in the Supply Chain industry. During my free time, I enjoy reading up on topics such as stock investing, insurance planning and property investment. Since 2012, I have started penning down my thoughts on certain financial matters while striving to achieve financial independence.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance